A systematic analysis of multiple myeloma and the related risk of HBV and HCV infection
10.3760/cma.j.issn.1008-1372.2018.08.008
- VernacularTitle:多发性骨髓瘤与HBV及HCV感染相关性的系统评价
- Author:
Ni LIU
1
;
Ruili YUAN
;
Jinyu YANG
;
Xuan GUO
Author Information
1. 710061,西安交通大学第一附属医院检验科
- Keywords:
Multiple myeloma/CO;
Hepatitis B/CO;
Hepatitis C/CO;
Meta-analysis
- From:
Journal of Chinese Physician
2018;20(8):1146-1150
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study aimed to assess the risk of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with multiple myeloma (MM) by systematic analysis.Methods The literature was retrieved in 4 English databases (PubMed,Web of science,OVID,Cochrane Library)and 3 Chinese databases (CNKI,VIP,and Wanfang) as of september 2016.The key word in English/Chinese database retrieval is " MM or multiple myeloma and infection".Newcastle Ottawa Scale (NOS) was used to evaluate the article quality.The overall odds ratio (OR) and 95％ confidence intervals (95％ Cls)were estimated by fixed (heterogeneity test at/2 ＜ 25％) or random (heterogeneity test atI2 ≥25％) effects model.Results A total of 9 studies were included in the Meta analysis.The study found that multiple myeloma patients had an increased risk of HBV and HCV infection,3.17 and 4.16 times higher than the control group.HBV (OR =3.17,95％ CI:1.17-1.96,I2 =27％,P =0.002) and HCV infection (OR =4.16,95％ CI:1.33-2.22,I2 =0％,P ＜0.001) in the multiple myeloma group were significantly different from those of the control group (P ＜ 0.05).Conclusions HBV and HCV infection are risk factors for multiple myeloma and should be highly regarded and controlled before and after treatment.
